Retained Earnings (Accumulated Deficit) in GBP of TC BioPharm (Holdings) plc from Q4 2022 to Q4 2024

Taxonomy & unit
us-gaap: GBP
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
TC BioPharm (Holdings) plc quarterly Retained Earnings (Accumulated Deficit) history and change rate from Q4 2022 to Q4 2024.
  • TC BioPharm (Holdings) plc Retained Earnings (Accumulated Deficit) for the quarter ending 31 Dec 2024 was -£52.6M, a 30.1% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (GBP)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Quarterly Retained Earnings (Accumulated Deficit) (GBP)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 -52.6M -12.2M -30.1% 31 Dec 2024 20-F 09 May 2025
Q2 2024 -44.1M 30 Jun 2024 6-K 25 Nov 2024
Q1 2024 -42.2M 31 Mar 2024 10-Q 15 May 2024
Q4 2023 -40.4M -7.03M -21.1% 31 Dec 2023 20-F 09 May 2025
Q4 2022 -33.4M 31 Dec 2022 10-K 01 Apr 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.